000 | 01892 a2200517 4500 | ||
---|---|---|---|
005 | 20250516020124.0 | ||
264 | 0 | _c20110210 | |
008 | 201102s 0 0 eng d | ||
022 | _a2044-5377 | ||
024 | 7 |
_a10.1302/0301-620X.93B1.24987 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJensen, C D | |
245 | 0 | 0 |
_aReturn to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study. _h[electronic resource] |
260 |
_bThe Journal of bone and joint surgery. British volume _cJan 2011 |
||
300 |
_a91-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aArthroplasty, Replacement, Hip _xadverse effects |
650 | 0 | 4 |
_aArthroplasty, Replacement, Knee _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xadverse effects |
650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xtherapeutic use |
650 | 0 | 4 |
_aHip Prosthesis _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKnee Prosthesis _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMorpholines _xadverse effects |
650 | 0 | 4 |
_aPostoperative Care _xmethods |
650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
650 | 0 | 4 |
_aProsthesis-Related Infections _xetiology |
650 | 0 | 4 | _aReoperation |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRivaroxaban |
650 | 0 | 4 |
_aThiophenes _xadverse effects |
650 | 0 | 4 |
_aThromboembolism _xprevention & control |
650 | 0 | 4 | _aTinzaparin |
700 | 1 | _aSteval, A | |
700 | 1 | _aPartington, P F | |
700 | 1 | _aReed, M R | |
700 | 1 | _aMuller, S D | |
773 | 0 |
_tThe Journal of bone and joint surgery. British volume _gvol. 93 _gno. 1 _gp. 91-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1302/0301-620X.93B1.24987 _zAvailable from publisher's website |
999 |
_c20482893 _d20482893 |